Clinical trial
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms
NCT00443885 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- January 31, 2017
- Enrollment
- 500 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
gram negative organism